The FDA adverse-event record for rabbit

Rabbit Adverse Event Insights

The FDA Center for Veterinary Medicine database holds 305 adverse event reports for Rabbit, distributed across 17 distinct breeds currently tracked in the system. Of those reports, 115 involved a death outcome, producing a 37.7% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.

The most frequently reported clinical signs for Rabbit are Death (87 reports), Weight loss (32 reports), Anorexia (28 reports), Inappetence (28 reports), with Death leading the reaction traffic at 87 submissions. On the product side, Meloxicam is the single most-referenced drug with 67 reports, followed by Selamectin (66), Isoflurane (36), Imidacloprid + Moxidectin (36). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species, a useful starting point when comparing Rabbit reporting patterns against other companion animals in the dataset.

Of the 281 Rabbit reports with a coded outcome, Died accounts for the largest share at 35.6%. Annual submission volume spans 2,010 to 2,025 reports across the 16 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 17 tracked rabbit breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling, causation requires clinical investigation beyond what these aggregates can provide.